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iIntroduction
Laryngeal  aspergillosis  is  known  to  occur  in  immunocompro-
mised  states,  particularly  in  diabetes  mellitus,  tuberculosis,
and  human  immuno-deﬁciency  virus  (HIV)  infection,  and  is
associated  with  use  of  inhalational  steroids  and  cytotoxic
drugs.  Primary  laryngeal  aspergillosis  is  rare,  especially  in
immunocompetent  patients,  with  very  few  reported  cases
to  date.  It  often  mimics  the  pre-malignant  and  malignant
conditions  of  larynx,  and  responds  well  to  antifungals.  This
report  presents  a  case  of  primary  laryngeal  aspergillosis  in
an  immunocompetent  middle-aged  woman,  and  explores  the
current  pool  of  evidence  regarding  its  pathogenesis  and  clin-
ical  aspects.  To  date,  this  represents  the  only  comprehensive
review  on  the  topic.
Case report
A  45-year-old  woman  presented  with  progressive  hoarseness
for  two  months.  It  was  preceded  by  an  episode  of  sore  throat
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reserved.hich  subsided  with  medication.  There  was  no  history  of  dif-
culty  in  deglutition,  respiratory  distress,  and  voice  abuse.
here  was  no  recent-onset  loss  of  weight  and  appetite,  with
o  cough  or  evening  rise  in  temperature.  Neither  she  nor
ny  of  her  kin  had  history  of  pulmonary  tuberculosis.  She
as  not  addicted  to  tobacco  or  alcohol,  and  was  otherwise
ealthy.
Indirect  laryngoscopy  and  subsequent  ﬁber-optic  laryn-
oscopy  revealed  inﬂamed  vocal  cords  with  impaired
obility,  covered  with  dirty-white  necrotic  debris  resem-
ling  keratotic  patches  over  areas  of  congestion.  The
estibular  folds  were  edematous  (Fig.  1A).  There  was  no
alpable  cervical  lymph-node.  Stigmata  of  healing  or  active
nfection,  such  as  scar,  sinus,  or  ﬁstula  were  absent  in  the
eck.  Chest  X-ray  showed  no  evidence  of  active  or  healed
uberculosis.  Routine  hematologic  investigations  were  unre-
arkable;  she  was  non-diabetic  and  seronegative  for  HIV.
ith  a  provisional  diagnosis  of  glottic  malignancy,  she  was
cheduled  for  microlaryngeal  evaluation  under  general  anes-
hesia  with  a plan  for  biopsy.  It  was  revealed  at  this  stage
hat  the  lesion  resembling  early  malignancy  or  kerato-
is  was  actually  areas  of  leukoplakic  patch,  which  could
e  easily  scraped  off  as  a  creamy  layer,  leaving  a  raw
ndersurface.  Fungal  staining  of  scrapings  showed  branch-
ng  septate  hyphae,  morphologically  resembling  Aspergillus.
istology  from  vocal  cord  tissue  samples  revealed  necrotic
xudates  in  stroma  crowded  with  septate  ‘‘spaghetti-like’’
ungal  ﬁlaments  branching  at  ∼45◦, interspersed  with  shreds
f  squamous  epithelium  (Fig.  1B  and  C).  Culture  reports
rgia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights
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Figure  1  (A)  Fiber-optic  laryngoscopy  revealed  inﬂamed  vocal  cords  covered  with  dirty  white  necrotic  debris  (arrows)  that
resembled keratotic  patches  over  areas  of  congestion.  (B  and  C)  Histopathology  revealed  necrotic  exudates  in  tissue  stroma  crowded
w 45◦,
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iith septate  ‘‘spaghetti-like’’  fungal  ﬁlaments  branching  at  ∼
hematoxylin--eosin;  400×).
orroborated  the  histology  ﬁndings,  conﬁrming  the  growth
s  Aspergillus  fumigatus.
A  retrospective  medical  history  based  on  the  clinico-
istologic  ﬁndings  revealed  that  the  patient  had  no  bronchial
sthma  or  any  sort  of  allergy.  Further  investigations  were
irected  at  any  co-morbid,  contributory  factors  that  could
ave  led  to  a  transient  immunodeﬁciency.  However,  she
ad  no  history  of  intake  of  inhalational  corticosteroids  or
ytotoxic  drugs,  nor  any  exposure  to  radiation.  That  she
as  non-diabetic  was  known  from  the  routine  pre-operative
heck-up.  Subsequent  investigations  failed  to  show  any
ocus  of  fungal  infestation  in  the  body.  This  included  the
racheo-bronchial  tree,  where  ﬂexible  bronchoscopy  and
ubsequent  culture  from  the  broncho-alveolar  lavage  were
nremarkable,  and  the  paranasal  sinuses,  which  showed  no
vidence  of  infection  on  diagnostic  nasal  endoscopy  and
maging.  A  diagnosis  of  primary  laryngeal  aspergillosis  was
eached,  and  the  patient  was  offered  oral  itraconazole
300  mg/day)  for  three  weeks.  Fiber-optic  laryngoscopy  per-
ormed  ten  days  following  therapy  showed  her  vocal  cords
o  be  edematous,  but  without  any  white  patches  or  debris.
he  was  followed  up  every  two  months.  At  six  months,  her
oice  had  returned  to  normal,  with  no  residual  lesion.
iscussion
spergillus  sp.  are  ubiquitous,  saprophytic  fungi  that
row  on  soil  and  decaying  matter.  However,  they  also
esult  in  opportunistic  infections  (sinusitis,  bronchitis,  aller-
ic  bronchopulmonary  aspergillosis,  aspergilloma,  invasive
spergillosis)  whose  severity  depends  upon  the  virulence
f  the  species  (A.  fumigatus,  A.  ﬂavus, and  A.  niger)
nd  on  the  host’s  immunity.1 The  inhaled  spores  deposit
n  the  mucosa  of  the  paranasal  sinuses,  larynx,  and
he  tracheobronchial  tree,  and  the  dark  airway  cavities
avor  their  growth  as  hyphae.  There  they  colonize  or
nvade  deeper  tissues,  producing  symptoms  when  host
mmunity  wanes.  Laryngotracheobronchial  and  pulmonary
spergilloses  therefore  represent  a  group  of  the  dreaded
omplications  of  immunocompromization.  They  might
arely  be  seen  in  immunocompetent  individuals  as  well.
5
t
r
w interspersed  with  shreds  of  vocal  cord  squamous  epithelium
owever,  primary  aspergillosis  restricted  to  the  larynx  in
 non-immunocompromized  subject  is  truly  rare.2 A  thor-
ugh  search  in  the  PubMed/MEDLINE,  LILACS,  and  SciELO
atabases  revealed  only  27  cases  in  the  English  literature
Table  1).
Little  is  known  about  the  etiopathogenesis  of  pri-
ary  laryngeal  aspergillosis  in  immunocompetent  subjects,
rimarily  because  of  limited  documentation,  which  are
ostly  single-case  reports.  Aspergillosis  is  essentially  oppor-
unistic,  and  host  immunity  is  the  key  in  production  of
linical  disease  rather  than  the  virulence  of  the  fungus,1,3
lthough  it  is  not  clear  how.4 Besides  the  known  states  of
mmunocompromization  (Table  2;  Group  A),  it  may  affect
‘apparently  healthy’’  subjects,  probably  because  a  person
‘asymptomatic’’  at  the  point  of  contracting  the  disease
ight  not  be  fully  immunocompetent;  rather,  she/he  could
e  in  a  transient  phase  of  waning  of  immunity.  This  could
e  possible  in  some  given  conditions  (Table  2;  Group  B).
lmost  all  of  them  are  systemic  factors  altering  host  immu-
ity,  except  for  inhaled  steroids  in  powder  form,  and  prior
xposure  to  irradiation  and  LASER  as  part  of  the  treatment
rotocol  for  laryngeal  carcinoma.
Besides,  there  are  some  ‘‘local’’  or  ‘‘laryngo-tropic’’
actors  (Table  2;  Group  C)  whose  true  role  in  the  patho-
enesis  remains  conjectural.  Many  patients  had  history  of
oice  abuse  (∼14%),  smoking  (∼11%),  and  radiation  expo-
ure  (∼11%)  (Fig.  2;  Table  1).  It  has  been  postulated  that  they
ause  microtrauma  to  the  vocal  fold  ultrastructure,  albeit  in
ifferent  ways,  and  alter  the  protective  physiology,  precipi-
ating  fungal  infection.2 The  local  microbial  environment  is
lso  altered  by  broad-spectrum  antibiotics.  Primary  laryn-
eal  aspergillosis  has  been  noted  in  patients  with  bronchial
sthma  who  chronically  use  inhalational  steroids  in  powder
orm  (Table  1).  The  powder  granules  deposit  over  the  laryn-
eal  epithelium  and  decrease  local  defense.  Ran  et  al.  have
ecently  implicated  the  practice  of  oral  sex  among  women
s  a potential  etiology.5 In  fact,  there  has  been  a  remarkable
ncrease  in  female  preponderance  from  the  overall  1.08  to in  the  last  14  years  (Table  1).  The  average  age  of  presen-
ation  has  also  decreased  --  almost  all  women  were  in  the
eproductive  age  group.  The  reason  for  this  skew  in  favor  of
omen  and  younger  age  is  not  clear,  but  it  would  perhaps
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Table  1  Primary  laryngeal  aspergillosis  in  immunocompetent  individuals  reported  in  English-language  indexed  literature.
Sl.  no.  Citations  Age
(years)/sex
Presentation  Associated  factors  Initial  diagnosis
1.  Present  case;  2015  45/F  Hoarseness  of  voice  None  Malignancy
2. Gangopadhyay  M,
Majumdar  K,
Bandyopadhyay  A,  Ghosh
A.  Invasive  primary
aspergillosis  of  the  larynx
presenting  as  hoarseness
and  a  chronic  nonhealing
laryngeal  ulcer  in  an
immunocompetent  host:
A  rare  entity.  Ear  Nose
Throat  J.  2014;93:265--8.
42/M  Hoarseness  of  voice,
fever,  cough  with
expectoration
Smoking,  vocal  abuse  Malignancy
3. Al-Ogaili  Z,  Chapeikin  G,
Palmer  D.  Primary
aspergillosis  of  bilateral
laryngoceles.  Case  Rep
Med.  2014;2014:384271.
77a/F  Difﬁculty  in
swallowing  and
talking,  hoarseness  of
voice
Smoking,  use  of
inhaled
corticosteroids  for
asthma
Lymphoma
4. Doloi  PK,  Baruah  DK,
Goswami  SC,  Pathak  GK.
Primary  aspergillosis  of
the  larynx:  a  case  report.
Indian  J  Otolaryngol
Head  Neck  Surg.
2014;66(Suppl.  1):326--8.
35/F  Hoarseness  of  voice,
cough
None  Keratosis
laryngis
5. Ran  Y,  et  al.  20135 23/F  Hoarseness  of  voice,
severe  paroxysmal
cough,  tachypnea
Oral  sex  None
6. Sundarray  C,  Panda  S,
Ray  R.  Primary  vocal  cord
aspergillosis  in  a  non-
immunocompromised
host.  J  Indian  Med  Assoc.
2011;109:200.
NA  NA  NA  NA
7. Ran  Y,  et  al.  20112 30/F  Hoarseness  of  voice,
preceded  by  an
episode  of  common
cold  (fever,
headache,  cough),
later  associated  with
vocal  fatigue,
expectoration,  and
occasional  vomiting
Vocal  abuse,  oral
antibiotics
(ampicillin,
ceﬁxime),  repeated
intra-laryngeal
injection  of
dexamethasone
Laryngitis
8. Liu YC,  et  al.  20104 30a/F Hoarseness  of  voice Vocal  abuse,  true
vocal  cord  cyst
None
32/F Vocal  abuse,  therapy
with  broad-spectrum
antibiotics
9. Ran  Y,  et  al.  20083 36/F  Hoarseness  of  voice,
vocal  fatigue
Systemic  antibiotic
(penicillin,
cefotaxime)  and
dexamethasone
therapy  for  rhinitis
and  asthma
None
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Table  1  (Continued)
Sl.  no.  Citations  Age
(years)/sex
Presentation  Associated  factors  Initial  diagnosis
10.  Wittkopf  J,  Connelly  S,
Hoffman  H,  Smith  R,
Robinson  R.  Infection  of
true  vocal  fold  cyst  with
Aspergillus. Otolaryngol
Head  Neck  Surg.
2006;135:660--1.
62/F  Hoarseness  of  voice  True  vocal  fold  cyst
(?  aspergilloma)
NA
11. Ogawa  Y,  et  al.  20021 73a/M  Hoarseness  of  voice  History  of
radiotherapy  for
laryngeal  squamous
cell  carcinoma;
history  of  diabetesc
Malignancy
12. Dean  CM,  Hawkshaw  M,
Sataloff  RT.  Laryngeal
aspergillosis.  Ear  Nose
Throat  J.  2001;80:300.d
17/F  Hoarseness  of  voice,
vocal  fatigue
None  NG
13. Fairfax  AJ,  et  al.  19997,d 75e/M  Hoarseness  of  voice
ultimately  leading  to
aphonia
Long  term  use  of
inhalational  steroid
(ﬂuticasone)  through
diskhaler,  history  of
chronic  smoking  for
40 years,  past  history
of  carcinoma
prostrate  treated
with  bilateral
orchidectomy
None
14. Beust L,  Godey  B,  Le  Gall  F,
Grollier  R,  Le  Clech  G.
Primary  aspergillosis  of  the
larynx  and  squamous  cell
carcinoma.  Ann  Otol  Rhinol
Laryngol.  1998;  107(10  Pt  1):
851--4.
53/M Hoarseness  of  voice,
respiratory  distress
Radiotherapy  for
squamous  cell
carcinoma  larynx
Nonef
64/M
15. Nong  D,  et  al.  19976 30--40g/4M
4F
Hoarseness  of  voice
leading  to  aphonia,
mild  sore  throat,
occasional  cough
(in  severe  cases)
None  Acute
laryngitis,
tuberculosis,
malignancy
16. Benson-Mitchell  R,  Tolley
N,  Croft  CB,  Gallimore  A.
Aspergillosis  of  the
larynx.  J  Laryngol  Otol.
1994;108:883--5.
62/M  Hoarseness  of  voice  None  Malignancy
17. Kheir  SM,  Flint  A,  Moss
JA.  Primary  aspergillosis
of  the  larynx  simulating
carcinoma.  Hum  Pathol.
1983;14:184--6.
50/M  Hoarseness  of  voice  Chronic  obstructive
pulmonary  disease
Malignancy
18. Ferlito  A.  Primary
aspergillosis  of  the
larynx.  J  Laryngol  Otol.
1974;88:1257--63.
76/M  Hoarseness  of  voice  None  NA
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Table  1  (Continued)
Sl.  no.  Citations  Age
(years)/sex
Presentation  Associated  factors  Initial  diagnosis
19.  Rao  PB.  Aspergillosis  of
larynx.  J  Laryngol  Otol.
1969;83:377--9.
48/M  Hoarseness  of  voice  None  NA
In most cases, unless otherwise mentioned, itraconazole was the preferred anti-fungal agent.
a Surgery was the mainstay of treatment [excision of laryngoceles (serial no. 3), excision of vocal cord cyst (serial no. 8), CO2 laser
cautery (serial no. 11)].
b Data from this citation could not be retrieved, as the journal website is now non-existent.
c According to the authors, prior radiation exposure was the more probable contributory factor for the laryngeal aspergillosis in this
patient rather than diabetes.
d These citations have been retrieved as cross-references from the articles obtained following the search strategy described in the
text.
e Treated with amphotericin lozenges.
f The lesions acted as harbingers of recurrence of the laryngeal cancer.
e pa
C
pg Treated with amphotericin B (one patient), ketoconazole (thre
NA: not available; NG: not given; M: male; F: female.
be  too  early  to  conclude  any  deﬁnitive  role  of  oral  sex  in
primary  laryngeal  aspergillosis.Interestingly,  50%  of  immunocompetent  subjects  with
primary  laryngeal  aspergillosis  had  no  identiﬁable  con-
tributory  factors  that  could  have  somehow  decreased  or
altered  the  protective  laryngeal  physiology  (Fig.  2;  Table  1).
m
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Table  2  Suggested  etiologic  factors  for  primary  laryngeal  asperg
Group  A  Conditions  leading  to  an
immunocompromized
state
•  Acq
• Unc
•  Mal
•  Sev
• Pro
• Lon
• Act
• Tra
• On  
•  Chr
•  Chr
• Ter
• Pro
• On  
Group B  Conditions  leading  to
transient  systemic/local
immunodeﬁciency  in  an
individual  who  can  be
otherwise  asymptomatic
at  the  time  of
contracting  the  disease
•  Hum
• Dia
• Ora
• Prio
• Tre
• Pas
•  Alc
• Chr
• On  
•  Fut
• Use
Group C  Associated  conditions
with  only  hypothetical
explanation
•  Voc
• Tru
• Ora
• Smo
• Occ
• Lartients), and itraconazole (four patients).
onsequently,  the  diagnosis  is  not  straightforward.  In  most
atients,  including  the  present  one,  the  condition  has  been
istaken  clinically  as  malignancy  (including  lymphoma)  and
eratosis  laryngis.  In  the  largest  series  published,  none
ad  a  correct  pre-operative  diagnosis.6 The  current  patient
resented  with  hoarseness  and  had  irregular  leukoplakic
illosis.
uired  immunodeﬁciency  syndrome
ontrolled  diabetes
ignancy  (especially  hematologic)
ere  aplastic  anemia
longed  neutropenia
g-term  systemic  steroid  intake
ive  tuberculosis
nsplant  recipients
cytotoxic  drugs
onic  liver  disease
onic  debilitating  illness
minal  illness
longed  hospitalization
parenteral  nutrition
an  immunodeﬁciency  virus  infection
betes  under  control
l  steroid  spray  (powder  form)  and  improper  mouthwash
r  irradiation
atment  with  LASER
t  history  of  tuberculosis
oholism
onic  obstructive  pulmonary  disease
dialysis
ure  recurrence  of  laryngeal  cancer
 of  broad  spectrum  antibiotics
al  abuse
e  vocal  cyst
l  sex
king
upation  (ﬁeld  work,  farming,  carpentry)
yngocele
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Figure  2  Proportionate  involvement  of  the  different  factors
associated  with  primary  laryngeal  aspergillosis  in  immunocom-
petent  subjects  (expressed  in  percentages).  Note  that  in  50%  of
the patients,  no  contributory  factor  could  be  elicited.  (Data
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Figure  3  Time-trend  of  the  number  of  cases  of  primary
laryngeal  aspergillosis  reported  in  immunocompetent  patients
in the  last  ﬁve  decades.  The  linear  black  line  with  arrow-
head represents  the  trend-line.  There  has  been  a  signiﬁcant
increase  in  reporting,  especially  after  1995,  although  eight
of the  11  patients  reported  in  the  time-period  of  1996--2000
were from  a  case-series  that  spanned  ten  years.  Nevertheless,
the elevation  of  the  trend-line  with  time  is  remarkable.  Pri-
mary laryngeal  aspergillosis  is  now  a  disease  to  look  for  in
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sor  of  Dermatology,  West  China  Hospital,  Sichuan  University,ere unavailable  in  one  patient.)  COPD,  chronic  obstructive
ulmonary  disease.
atches  over  the  vocal  cords  --  the  typical  presentation  of
rimary  aspergillosis  limited  to  the  larynx  with  variable  sub-
lottic  and  supraglottic  extensions.  However,  it  can  also
anifest  as  ulcerative  plaques,  as/within  vocal  cysts,  and
ven  within  bilateral  laryngoceles  (Table  1),  adding  to  the
linical  dilemma.
Histopathology  is  essential  for  correct  diagnosis;
t  demonstrates  the  septate  hyphae  with  characteris-
ic  dichotomous  branching  at  45◦.2,4 Culture  patterns
sabouraud  dextrose  agar  at  28 ◦C),  and  presently  gene
xtraction  through  a  pre-formed  ‘‘DNA-kit’’  and  subsequent
mpliﬁcation  by  polymerase  chain  reaction,  followed  by
equencing  in  specialized  laboratories  provide  for  the
pecies  of  Aspergillus  involved.2--5 Decision  regarding
dministration  of  systemic  antifungals  is  controversial,  as
spergillosis  is  chieﬂy  colonizing  rather  than  invasive.  How-
ver,  histologic  evidence  of  invasion  has  been  demonstrated
n  immunocompetent  subjects  presenting  with  hoarseness.
he  situation  is  akin  to  fungal  rhinosinusitis  when  systemic
ntifungals  are  preferentially  administered  only  when
here  is  osseo-neurovascular  involvement.  Nevertheless,
n  primary  laryngeal  aspergillosis,  oral  itraconazole  for
hree-to-four  weeks  has  been  the  standard  treatment  in
ost  published  reports  irrespective  of  invasion.2--5 Use
f  ketoconazole  and  amphotericin  B  lozenges  has  been
entioned  in  few  earlier  reports,6,7 but  itraconazole,  with
ewer  side-effects  and  satisfactory  outcome,  is  presently
avored.  Data  on  long-term  follow-up  is  lacking,  but  to  date
here  has  been  no  recurrence  following  complete  treatment
ith  systemic  antifungals.
Lack  of  deﬁnite  guidelines  for  clinical  diagnosis  due  of  the
arity  of  the  disease  might  have  resulted  in  under-reporting,
ut  presently  primary  laryngeal  aspergillosis  in  immuno-
ompetent  subjects  should  be  considered  an  ‘‘emerging
isease  entity.’’  Analysis  of  the  frequency  of  cases  in  the
ve-year-wise  split  since  its  ﬁrst  documentation  shows  that
here  has  been  a  steep  rise  of  the  trend-line  (Fig.  3).
herefore,  it  might  not  be  as  uncommon  as  generally
onsidered.  Although  the  host-pathogen  interaction  in  cau-
ation  of  the  disease  is  still  unknown,  primary  laryngeal
spergillosis  currently  represents  an  entity  that  present-day
C
D
rymptomatic  immunocompetent  individuals.  (n.b.:  the  present
atient  has  been  included  in  the  2011--2014  group).
tolaryngologists  are  expected  to  encounter  more  often  in
on-immunocompromized  individuals.
onclusions
he  incidence  of  primary  laryngeal  aspergillosis  in  immuno-
ompetent  individuals  has  been  steadily  rising  in  the  last
ew  years.  An  easily  removable  white  patch  (leukoplakia),
 small  slough-covered  ulcer,  or  a vocal  nodule  in  a  healthy
atient  presenting  with  hoarseness  with  no  apparent  expo-
ure  to  any  known  immunomodulatory  agent/environment
hould  arouse  suspicion  of  primary  aspergillosis.  Etiologic
actors  are  often  difﬁcult  to  elicit,  and  immunity  might  not
lay  a  deﬁnitive  role  in  the  causation.  However,  knowledge
f  the  suggested  contributory  factors  with  a  high  index  of
uspicion  would  help  clinicians  direct  their  work-up  accord-
ngly  to  exclude  the  differentials,  thereby  aiding  to  detect
his  potentially  curable  disease  in  time,  irrespective  of  the
tatus  of  the  host’s  immunity.
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